Combined, THOR methylation defines a novel risk group for PCa where in lower Gleason 6 and 7 (3 + 4) THOR predicts outcome (p = 0.007) while this signature is lost in higher Gleason scores (Figure 2C and 2D). The gene discussed is THORLNC; the disease is posterior cortical atrophy.